Genetic Counselors' Experiences Regarding Communication of Reproductive Risks with XXXX found on Cancer Panels.

@entity1 @entity10479 @entity5 @entity14183 @entity74 @entity1129 @entity4310 @entity11807
UNASSIGNED: The development of @entity4310 genetic testing panels has altered genetic counseling practice. Mutations within certain genes on @entity5 panels pose not only a @entity5 risk, but also a reproductive risk for @entity74 such as @entity11807 , constitutional mismatch @entity14183 , @entity1129 . This study aimed to determine if genetic counselors discuss reproductive risks for @entity74 associated with genes included on @entity5 panels, and if so, under what circumstances these risks are discussed. An on-line survey was emailed through the NSGC list-serv. The survey assessed 189 @entity5 genetic counselors' experiences discussing reproductive risks with @entity1 at risk to carry a mutation or @entity10479 ( @entity10479 ) in a gene associated with both an @entity5 risk and an @entity74 . Over half (n  =  82, 55  %) reported having discussed reproductive risks; the remainder (n  =  66, 45  %) had not. Genetic counselors who reported discussing reproductive risks primarily did so when @entity1 had a positive result and were of reproductive age. Reasons for not discussing these risks included when a @entity1 had completed childbearing or when a @entity10479 was identified. Most counselors discussed reproductive risk after obtaining results and not during the informed consent process. There is inconsistency as to if and when the discussion of reproductive risks is taking place. The wide variation in responses suggests a need to develop professional guidelines for when and how discussions of reproductive risk for @entity74 identified through @entity5 panels should occur with @entity1 .
